Stock Events

Stock Events

Celon Pharma SA 

€4.74
0
-€0.04-0.73% Today

Statistics

Day High
4.85
Day Low
4.73
52W High
5.96
52W Low
4.24
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8RP.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap161.09B
Pfizer Inc. is a global pharmaceutical company that competes in various therapeutic areas similar to those targeted by Celon Pharma.
Novartis
NVS
Mkt Cap297.32B
Novartis AG is involved in the research, development, and marketing of pharmaceutical products, directly competing with Celon Pharma in multiple markets.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline plc operates in the pharmaceutical and healthcare sector, offering products that compete in the same categories as Celon Pharma.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is a leading pharmaceutical company that develops medicines across many of the same fields as Celon Pharma.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca PLC engages in the development of pharmaceutical products that directly compete with Celon Pharma's product line.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol-Myers Squibb Company offers a range of biopharmaceutical products, competing with Celon Pharma in several therapeutic areas.
Sanofi
SNY
Mkt Cap116.63B
Sanofi operates globally in the pharmaceutical sector, with a product range that overlaps with Celon Pharma's market interests.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie Inc. focuses on pharmaceuticals in areas like immunology and oncology, directly competing with Celon Pharma.
Lilly(Eli) &
LLY
Mkt Cap837.36B
Eli Lilly and Company develops and markets pharmaceutical products in areas that compete with Celon Pharma's focus.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries Limited manufactures generic and specialty medicines, competing with Celon Pharma in various therapeutic areas.

About

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.
Show more...
CEO
Dr. Maciej Wieczorek Ph.D.
Employees
566
Country
DE
ISIN
PLCLNPH00015

Listings

STU
DE
8RP.STU
F
DE
8RP.F
WA
PL
CLN.WA
LSE
GB
0RKX.LSE

0 Comments

Share your thoughts

FAQ

What is Celon Pharma SA stock price today?▼
The current price of 8RP.STU is €4.74 EUR — it has decreased by -0.73% in the past 24 hours. Watch Celon Pharma SA stock price performance more closely on the chart.
What is Celon Pharma SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Celon Pharma SA stocks are traded under the ticker 8RP.STU.
Is Celon Pharma SA stock price growing?▼
8RP.STU stock has risen by +4.87% compared to the previous week, the month change is a -7.06% fall, over the last year Celon Pharma SA has showed a -14.13% decrease.
How many employees does Celon Pharma SA have?▼
As of April 10, 2026, the company has 566 employees.
In which sector is Celon Pharma SA located?▼
Celon Pharma SA operates in the Health Care sector.
When did Celon Pharma SA complete a stock split?▼
Celon Pharma SA has not had any recent stock splits.
Where is Celon Pharma SA headquartered?▼
Celon Pharma SA is headquartered in Lomianki, DE.